Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004255 |
---|---|
Receipt number | R000005071 |
Scientific Title | Phase II study of Bevacizumab and Erlotinib in patients with non-Squamous non-small cell lung cancer that is refractory or relapsed after 1-2 previous Treatment |
Date of disclosure of the study information | 2010/09/24 |
Last modified on | 2014/03/22 21:13:12 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/09/22 19:52:01 | ||
2 | Update | 2010/11/06 10:27:56 | Recruitment status Anticipated trial start date |
|
3 | Update | 2011/03/22 18:02:04 | Institutions |
|
4 | Update | 2011/09/22 19:26:24 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
5 | Update | 2012/10/01 21:00:34 | Recruitment status |
|
6 | Update | 2012/10/01 21:02:59 | Institutions |
|
7 | Update | 2013/09/22 11:37:13 | Email |
|
8 | Update | 2013/09/22 11:37:51 | Publication of results |
|
9 | Update | 2014/03/22 21:13:12 | Recruitment status |